Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-06-17 Sale |
2025-06-18 6:02 pm |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
911 | $30.24 | $27,549 | 50,392 (Direct) |
View |
2025-06-11 Sale |
2025-06-12 6:18 pm |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
20,000 | $32.88 | $657,694 | 176,695 (Direct) |
View |
2025-06-02 Sale |
2025-06-04 4:48 pm |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $32.48 | $190,833 | 73,150 (Direct) |
View |
2025-05-01 Sale |
2025-05-02 7:55 pm |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $32.4 | $190,324 | 79,025 (Direct) |
View |
2025-04-01 Sale |
2025-04-03 4:56 pm |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $27.83 | $163,486 | 98,729 (Direct) |
View |
2025-03-20 Sale |
2025-03-21 6:44 pm |
Avidity Biosciences Inc. | RNA | Hughes Steven George Chief Medical Officer |
9,578 | $31.06 | $297,491 | 72,850 (Direct) |
View |
2025-03-20 Sale |
2025-03-21 6:42 pm |
Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO |
31,540 | $31.06 | $979,563 | 305,871 (Direct) |
View |
2025-03-20 Sale |
2025-03-21 6:40 pm |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
11,780 | $31.06 | $365,868 | 80,195 (Direct) |
View |
2025-03-20 Sale |
2025-03-21 6:38 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
7,935 | $31.06 | $246,425 | 96,720 (Direct) |
View |
2025-03-20 Sale |
2025-03-21 6:36 pm |
Avidity Biosciences Inc. | RNA | McCarthy Teresa Chief Human Resources Officer |
7,778 | $31.06 | $241,583 | 97,130 (Direct) |
View |
2025-03-11 Sale |
2025-03-12 4:23 pm |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
20,000 | $30.13 | $602,614 | 208,475 (Direct) |
View |
2025-03-03 Sale |
2025-03-04 6:17 pm |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $29.41 | $172,807 | 69,929 (Direct) |
View |
2025-02-03 Sale |
2025-02-05 5:01 pm |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $32.16 | $188,918 | 85,229 (Direct) |
View |
2025-01-21 Sale |
2025-01-23 8:17 pm |
Avidity Biosciences Inc. | RNA | LEVIN ARTHUR A Director |
1,872 | $28.6 | $53,537 | 144,330 (Indirect Direct) |
View |
2025-01-21 Sale |
2025-01-23 8:15 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
3,287 | $28.59 | $93,985 | 104,655 (Direct) |
View |
2025-01-21 Sale |
2025-01-23 8:14 pm |
Avidity Biosciences Inc. | RNA | McCarthy Teresa Chief Human Resources Officer |
2,959 | $28.59 | $84,612 | 104,908 (Direct) |
View |
2025-01-21 Sale |
2025-01-23 8:12 pm |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
5,672 | $28.6 | $162,192 | 91,975 (Direct) |
View |
2025-01-21 Sale |
2025-01-23 8:10 pm |
Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO |
10,397 | $28.59 | $297,291 | 337,411 (Direct) |
View |
2025-01-21 Sale |
2025-01-23 8:08 pm |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
9,411 | $29.53 | $277,912 | 50,554 (Direct) |
View |
2025-01-21 Sale |
2025-01-23 8:06 pm |
Avidity Biosciences Inc. | RNA | Hughes Steven George Chief Medical Officer |
3,947 | $28.59 | $112,856 | 82,428 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-06-10 Option Award |
2025-06-12 6:42 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | Henig Noreen Director |
16,726 | $0 | 16,726 (Direct) |
View |
2025-06-10 Option Award |
2025-06-12 6:40 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | BOESS CARSTEN Director |
16,726 | $0 | 16,726 (Direct) |
View |
2025-06-10 Option Award |
2025-06-12 6:37 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | Kaye Edward M. MD Director |
16,726 | $0 | 16,726 (Direct) |
View |
2025-06-10 Option Award |
2025-06-12 6:35 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | LEVIN ARTHUR A Director |
16,726 | $0 | 161,056 (Direct) |
View |
2025-06-10 Option Award |
2025-06-12 6:30 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | Skerjanec Simona Director |
16,726 | $0 | 16,726 (Direct) |
View |
2025-06-10 Option Award |
2025-06-12 6:26 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | WILSON TROY EDWARD Director |
16,726 | $0 | 79,459 (Direct) |
View |
2025-06-10 Option Award |
2025-06-12 6:24 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | Thompson Tamar Director |
16,726 | $0 | 16,726 (Direct) |
View |
2025-06-10 Option Award |
2025-06-12 6:20 pm |
N/A 2035-06-09 |
Avidity Biosciences Inc. | RNA | Kim Jean Jinsun Director |
16,726 | $0 | 16,726 (Direct) |
View |
2025-06-11 Exercise |
2025-06-12 6:18 pm |
N/A 2032-01-20 |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
20,000 | $0 | 176,695 (Direct) |
View |
2025-06-11 Exercise |
2025-06-12 6:18 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
20,000 | $14.22 | 176,695 (Direct) |
View |
2025-06-02 Exercise |
2025-06-04 4:48 pm |
N/A 2032-07-17 |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $0 | 73,150 (Direct) |
View |
2025-06-02 Exercise |
2025-06-04 4:48 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $16.65 | 73,150 (Direct) |
View |
2025-05-01 Exercise |
2025-05-02 7:55 pm |
N/A 2032-07-17 |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $0 | 79,025 (Direct) |
View |
2025-05-01 Exercise |
2025-05-02 7:55 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $16.65 | 79,025 (Direct) |
View |
2025-04-01 Exercise |
2025-04-03 4:56 pm |
N/A 2032-01-19 |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $0 | 98,729 (Direct) |
View |
2025-04-01 Exercise |
2025-04-03 4:56 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,546 | $14.7 | 98,729 (Direct) |
View |
2025-04-01 Exercise |
2025-04-03 4:56 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
329 | $16.65 | 98,729 (Direct) |
View |
2025-03-11 Exercise |
2025-03-12 4:23 pm |
N/A 2032-01-20 |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
20,000 | $0 | 208,475 (Direct) |
View |
2025-03-11 Exercise |
2025-03-12 4:23 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
20,000 | $14.22 | 208,475 (Direct) |
View |
2025-03-03 Exercise |
2025-03-04 6:17 pm |
N/A 2032-01-19 |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $0 | 69,929 (Direct) |
View |
2025-03-03 Exercise |
2025-03-04 6:17 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $14.7 | 69,929 (Direct) |
View |
2025-02-03 Exercise |
2025-02-05 5:01 pm |
N/A 2032-07-17 |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $0 | 85,229 (Direct) |
View |
2025-02-03 Exercise |
2025-02-05 5:01 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
5,875 | $16.65 | 85,229 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:35 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | Flanagan W. Michael Chief Scientific Officer |
75,000 | $0 | 147,647 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:31 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | McCarthy Teresa Chief Human Resources Officer |
75,000 | $0 | 157,867 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:29 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | Moriarty John B Chief Legal Officer |
75,000 | $0 | 100,000 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:26 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
75,000 | $0 | 157,942 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:24 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | Boyce Sarah President and CEO |
247,500 | $0 | 512,808 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:22 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | Hughes Steven George Chief Medical Officer |
75,000 | $0 | 136,375 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:16 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
75,000 | $0 | 109,965 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:14 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | Mosbrooker Eric Chief Commercial Officer |
75,000 | $0 | 111,120 (Direct) |
View |
2025-01-06 Option Award |
2025-01-08 8:13 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | Calderaro Charles III Chief Technical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
Ownership |
2025-01-08 7:04 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Mosbrooker Eric Chief Commercial Officer |
0 | $0 | 351,120 (Direct) |
View |
Ownership |
2025-01-08 6:52 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Gallagher Kathleen P. Chief Program Officer |
0 | $0 | 224,671 (Direct) |
View |
Ownership |
2025-01-08 6:46 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | Hughes Steven George Chief Medical Officer |
0 | $0 | 383,668 (Direct) |
View |